An interventional study of Implant placement with flapped surgery and Implant placement with flapless surgery in Edentulous Mouth and Complete Edentulism, sponsored by Universidade Federal de Goias. Completed at 1 site in Brazil. Per ClinicalTrials.gov, last updated 2023-05-10.
Sponsored by Universidade Federal de Goias · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Mouth, Edentulous with a site in Brazil — none open to participants now, none under way, none of them phase 3. Mouth, Edentulous · Brazil.
Among the 13 studies in Mouth, Edentulous with a site in Brazil, this one is the 5th largest by enrollment, is the only one that started in 2021, is one of 12 with no phase, and was the 13th registered.
124 studies on the registry are indexed under Mouth, Edentulous; 17 are open to participants now.
Browse Mouth, Edentulous studies →None of the 13 studies in Mouth, Edentulous with a site in Brazil is open now. The open studies under Mouth, Edentulous, anywhere →
Of the 11 Mouth, Edentulous studies recruiting now, 6 (55%) set no upper age limit and 5 (45%) stop at 75 or younger; none take children under 18; 6 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2021.
This study's enrollment of 74 is above the median of 36 across 93 interventional studies indexed under Mouth, Edentulous.
Median enrollment 60 across the 13 interventional studies. Of the 11 that completed or were terminated, 1 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 6 most frequent:
Universidade Federal de Goias is the lead sponsor of 42 studies on the registry; 3 are open to participants now.
Universidade Federal de Goias has 7 studies filed under Mouth, Edentulous — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Mouth, Edentulous with a site in Brazil, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to test the combined effects of different loading protocols and surgical approaches on clinical and patient-reported outcome measures (PROMs) following the use of four mini implants for mandibular overdenture retention.
The main study hypotheses are:
This study aims to test the combined effects of different loading protocols and surgical approaches on clinical and patient-reported outcome measures (PROMs) following the use of four mini implants for mandibular overdenture retention.
Main study hypotheses:
Statement of clinical relevance:
Mini implants are an alternative to standard implants for overdentures. They are suitable for insertion in narrow ridges, are less invasive, simpler, less costly, and faster to perform, and are especially advantageous for older and frail patients who would benefit from more conservative and less burdensome treatments. Although previous studies reported favorable outcomes regarding patient oral comfort and function, there is a need for implant/attachment systems with higher predictability on implant survival and retention performance in the long-term. This study aims to provide clinical evidence on the newly developed 2.4mm one-piece TiZr mini implant with a miniaturized carbon-based coating attachment.
Methods:
This is a randomized clinical trial using a factorial design, to test the effectiveness of a mandibular overdenture retained by four mini implants. Participants will be randomized using a 2×2 factorial design: immediate/delayed loading (factor 1) and flapless/flapped surgery (factor 2). New conventional complete dentures will be provided as the baseline treatment. Next, eligible participants will be those who completed a 6-month period of denture usage, and are in need of implants to improve the function of the mandibular denture. Imaging exam should present a minimum of 5.4 mm of ridge width in the interforaminal region (recommended for flapless surgery).
Included subjects to take part in the RCT will be randomized to the treatment groups according to the combined study factors - loading protocols: immediate (IL) or delayed (DL); and surgical approaches: flapless (FLS) or flapped (FPS) surgery. Hence, the combined factors will results in four groups:
All participants will receive four Straumann® Mini Implant System (one-piece Tissue Level implants) with an Optiloc® prosthetic connection and PEEK matrix inserts. Surgery will follow the workflow for the surgical procedure for the Straumann® Mini Implant System concerning preoperative planning, implant bed preparation and implant insertion. For the prosthetic procedures, we will perform a chairside incorporation of the retentive inserts to convert the existing well-fitting and well-functioning lower denture into an overdenture with the Optiloc® Retentive System/Straumann® Mini Implants.
Outcomes will include short-term outcomes (Patient perceived burdens in surgery, postoperative swelling and pain, consumption of analgesics and surgical time) and long-term - 1-year (implant survival and success, peri-implant marginal bone level changes, PROMs, retention force, prosthodontic events) outcomes. Sample size calculation resulted in a total of 74 participants, 18 in each of the four groups. Data analysis will include descriptive and bivariate analyses, Kaplan-Meier curves and regression models using Generalized Estimating Equations (GEE) for longitudinal data.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immediate loading (IL) and Flapless surgery (FLS)
Procedure: Implant placement with flapless surgery · Procedure: Implant immediate loading
Immediate loading (IL) and Flapped surgery (FPS)
Procedure: Implant placement with flapped surgery · Procedure: Implant immediate loading
Delayed loading (DL) and Flapless surgery (FLS)
Procedure: Implant placement with flapless surgery · Procedure: Implant delayed loading
Delayed loading (DL) and Flapped surgery (FPS)
Procedure: Implant placement with flapped surgery · Procedure: Implant delayed loading
Four mini implants will be placed reflecting a flap.
Four mini implants will be placed without reflecting a flap.
Four mini implants will be immediately loaded.
Four mini implants will be loaded after a 6-week healing period.
Patient-perceived burdens
The Burdens in Oral Surgery Questionnaire (BiOS-Q) will be used to assess patient-perceived burdens. It includes 16 items concerning all aspects of procedures occurring during a surgery. Responses for each item are assessed using a visual analogue scale (VAS) ranging from 0 = no expression of the attribute (e.g. not unpleasant at all) to 100 = maximum expression (e.g. very unpleasant).
Time frame: Twenty-four hours after implant surgery.
Implant survival and success
Each implant will be assessed according to the health scale of the International Congress of Oral Implantologists (ICOI-Pisa health scale). After clinical assessment, each implant will be classified as 'success', 'satisfactory survival', 'compromised survival' or 'failure'.
Time frame: Incidence thoughout the 12-month follow-up after implant placement.
Postoperative pain and discomfort
A 100-cm graduated visual analog scale will be used to evaluate participants' assessments of pain and discomfort regarding the surgical process. Each participant will indicate their level of pain and discomfort with each parameter by marking a point along the scale.
Time frame: Assessed 24 hours after implant placement.
Postoperative pain and discomfort
A 100-cm graduated visual analog scale will be used to evaluate participants' assessments of pain and discomfort regarding the surgical process. Each participant will indicate their level of pain and discomfort with each parameter by marking a point along the scale.
Time frame: Assessed 72 hours after implant placement.
Postoperative pain and discomfort
A 100-cm graduated visual analog scale will be used to evaluate participants' assessments of pain and discomfort regarding the surgical process. Each participant will indicate their level of pain and discomfort with each parameter by marking a point along the scale.
Time frame: Assessed 1 week after implant placement.
Consumption of analgesics
The number of analgesics consumed by the participant during the post-operative and healing period will be recorded in the patient's file.
Time frame: Assessed until 1 week after implant placement.
Patient Satisfaction
The McGill Denture Satisfaction Instrument - DSI (Awad \& Feine, 1998; de Grandmont et al., 1994) will be used to assess patients' satisfaction relating to their prostheses. This is a treatment-specific patient-based outcome assessing satisfaction relating to several aspects of the mandibular prosthesis, including general satisfaction, comfort, stability, aesthetics, chewing ability (ease of chewing), chewing efficiency (ability to crush food in small particles), ease of cleaning, ability to speak and oral condition (condition of their mouth, which can refer to oral health status and was measured by "In general, are you satisfied with your oral condition?''. The subjects will answer on a 100 mm visual analogue scale (VAS) anchored by the words 'not at all satisfied' and 'extremely satisfied'.
Time frame: Assessed at baseline (before implant surgery)
Patient Satisfaction
The McGill Denture Satisfaction Instrument - DSI (Awad \& Feine, 1998; de Grandmont et al., 1994) will be used to assess patients' satisfaction relating to their prostheses. This is a treatment-specific patient-based outcome assessing satisfaction relating to several aspects of the mandibular prosthesis, including general satisfaction, comfort, stability, aesthetics, chewing ability (ease of chewing), chewing efficiency (ability to crush food in small particles), ease of cleaning, ability to speak and oral condition (condition of their mouth, which can refer to oral health status and was measured by "In general, are you satisfied with your oral condition?''. The subjects will answer on a 100 mm visual analogue scale (VAS) anchored by the words 'not at all satisfied' and 'extremely satisfied'.
Time frame: Assessed at the 3-month follow-up visit after implant placement.
Patient Satisfaction
The McGill Denture Satisfaction Instrument - DSI (Awad \& Feine, 1998; de Grandmont et al., 1994) will be used to assess patients' satisfaction relating to their prostheses. This is a treatment-specific patient-based outcome assessing satisfaction relating to several aspects of the mandibular prosthesis, including general satisfaction, comfort, stability, aesthetics, chewing ability (ease of chewing), chewing efficiency (ability to crush food in small particles), ease of cleaning, ability to speak and oral condition (condition of their mouth, which can refer to oral health status and was measured by "In general, are you satisfied with your oral condition?''. The subjects will answer on a 100 mm visual analogue scale (VAS) anchored by the words 'not at all satisfied' and 'extremely satisfied'.
Time frame: Assessed at the 6-month follow-up visit after implant placement.
Patient Satisfaction
The McGill Denture Satisfaction Instrument - DSI (Awad \& Feine, 1998; de Grandmont et al., 1994) will be used to assess patients' satisfaction relating to their prostheses. This is a treatment-specific patient-based outcome assessing satisfaction relating to several aspects of the mandibular prosthesis, including general satisfaction, comfort, stability, aesthetics, chewing ability (ease of chewing), chewing efficiency (ability to crush food in small particles), ease of cleaning, ability to speak and oral condition (condition of their mouth, which can refer to oral health status and was measured by "In general, are you satisfied with your oral condition?''. The subjects will answer on a 100 mm visual analogue scale (VAS) anchored by the words 'not at all satisfied' and 'extremely satisfied'.
Time frame: Assessed at the 12-month follow-up visit after implant placement.
Oral health-related quality of life (OHRQoL)
The cross-culturally adapted Brazilian version of the Oral Health Impact Profile for edentulous subjects (OHIP-EDENT) will be used. It contains 19 items divided in four different subscale domains: (I) masticatory discomfort and disability (four items), (II) psychological discomfort and disability (five items), (III) social disability (five items), and (IV) oral pain and discomfort (five items). The items are answerable by a 3-point Likert scale and responses will be summed to result an overall score. Higher scores represent worse OHRQoL.
Time frame: Assessed at baseline (before implant surgery).
Oral health-related quality of life (OHRQoL)
The cross-culturally adapted Brazilian version of the Oral Health Impact Profile for edentulous subjects (OHIP-EDENT) will be used. It contains 19 items divided in four different subscale domains: (I) masticatory discomfort and disability (four items), (II) psychological discomfort and disability (five items), (III) social disability (five items), and (IV) oral pain and discomfort (five items). The items are answerable by a 3-point Likert scale and responses will be summed to result an overall score. Higher scores represent worse OHRQoL.
Time frame: Assessed at the 3-month follow-up visit after implant placement.
Oral health-related quality of life (OHRQoL)
The cross-culturally adapted Brazilian version of the Oral Health Impact Profile for edentulous subjects (OHIP-EDENT) will be used. It contains 19 items divided in four different subscale domains: (I) masticatory discomfort and disability (four items), (II) psychological discomfort and disability (five items), (III) social disability (five items), and (IV) oral pain and discomfort (five items). The items are answerable by a 3-point Likert scale and responses will be summed to result an overall score. Higher scores represent worse OHRQoL.
Time frame: Assessed at the 6-month follow-up visit after implant placement.
Oral health-related quality of life (OHRQoL)
The cross-culturally adapted Brazilian version of the Oral Health Impact Profile for edentulous subjects (OHIP-EDENT) will be used. It contains 19 items divided in four different subscale domains: (I) masticatory discomfort and disability (four items), (II) psychological discomfort and disability (five items), (III) social disability (five items), and (IV) oral pain and discomfort (five items). The items are answerable by a 3-point Likert scale and responses will be summed to result an overall score. Higher scores represent worse OHRQoL.
Time frame: Assessed at the 12-month follow-up visit after implant placement.
Prosthodontic maintenance events
The incidence of prosthodontic repair/adjustment events will be recorded during the clinical assessments.
Time frame: Throughout 12 months after overdenture delivery.
Surgical time
The time interval concerning the clinical visit for implant placement and delivery of the overdenture or denture adaptation will me measured and registered.
Time frame: Procedure (Assessed during the clinical visit of implant placement and overdenture delivery or denture adaptation.)
Masticatory Performance
To perform the masticatory performance test two gums in a dragée form will be used, one blue and one pink, which need to be stuck together manually by wetting them with water and applying moderate force. The participants will be instructed to chew 2 samples of the gum on theirs preferred chewing side for 20 and 50 chewing cycles, respectively, leaving an interval of 1 minute between each chewing sequence.
Time frame: Assessed at baseline (before implant surgery).
Masticatory Performance
To perform the masticatory performance test two gums in a dragée form will be used, one blue and one pink, which need to be stuck together manually by wetting them with water and applying moderate force. The participants will be instructed to chew 2 samples of the gum on theirs preferred chewing side for 20 and 50 chewing cycles, respectively, leaving an interval of 1 minute between each chewing sequence.
Time frame: Assessed at the 3-month follow-up visit after implant placement.
Masticatory Performance
To perform the masticatory performance test two gums in a dragée form will be used, one blue and one pink, which need to be stuck together manually by wetting them with water and applying moderate force. The participants will be instructed to chew 2 samples of the gum on theirs preferred chewing side for 20 and 50 chewing cycles, respectively, leaving an interval of 1 minute between each chewing sequence.
Time frame: Assessed at the 6-month follow-up visit after implant placement.
Masticatory Performance
To perform the masticatory performance test two gums in a dragée form will be used, one blue and one pink, which need to be stuck together manually by wetting them with water and applying moderate force. The participants will be instructed to chew 2 samples of the gum on theirs preferred chewing side for 20 and 50 chewing cycles, respectively, leaving an interval of 1 minute between each chewing sequence.
Time frame: Assessed at the 12-month follow-up visit after implant placement.
Maximum voluntary bite force
Maximum voluntary bite force will be measured with a digital gauge (IDDK - Kratos, Cotia, São Paulo, Brazil) in the region of the first molar with three assessments per side.
Time frame: Assessed at baseline (before implant surgery).
Maximum voluntary bite force
Maximum voluntary bite force will be measured with a digital gauge (IDDK - Kratos, Cotia, São Paulo, Brazil) in the region of the first molar with three assessments per side.
Time frame: Assessed at the 3-month follow-up visit after implant placement.
Maximum voluntary bite force
Maximum voluntary bite force will be measured with a digital gauge (IDDK - Kratos, Cotia, São Paulo, Brazil) in the region of the first molar with three assessments per side.
Time frame: Assessed at the 6-month follow-up visit after implant placement.
Maximum voluntary bite force
Maximum voluntary bite force will be measured with a digital gauge (IDDK - Kratos, Cotia, São Paulo, Brazil) in the region of the first molar with three assessments per side.
Time frame: Assessed at the 12-month follow-up visit after implant placement.
Peri-implant bone change
Periapical radiographs will be obtained and the peri-implant bone level will be measured and compared longitudinally.
Time frame: Peri-implant bone loss at the 3-month follow-up compared to initial stage (1-week rediograph).
Peri-implant bone change
Periapical radiographs will be obtained and the peri-implant bone level will be measured and compared longitudinally.
Time frame: Peri-implant bone loss at the 6-month follow-up compared to initial stage (1-week rediograph).
Peri-implant bone change
Periapical radiographs will be obtained and the peri-implant bone level will be measured and compared longitudinally.
Time frame: Peri-implant bone loss at the 12-month follow-up compared to initial stage (1-week rediograph).
Bleeding on probing
Incidence of inflammation of the peri-implant soft tissues
Time frame: Assessed at 6-month post-insertion
Bleeding on probing
Incidence of inflammation of the peri-implant soft tissues
Time frame: Assessed at 12-month post-insertion
Probing depth
Level of the peri-implant sulcus (in milimiters)
Time frame: Assessed at 6-month post-insertion
Probing depth
Level of the peri-implant sulcus (in milimiters)
Time frame: Assessed at 12-month post-insertion
Suppuration
Incidence of suppuration on probing the peri-implant soft tissues
Time frame: Assessed at 6-month post-insertion
Suppuration
Incidence of suppuration on probing the peri-implant soft tissues
Time frame: Assessed at 12-month post-insertion
Plan to share: Yes — Clinical data will be implemented electronically using a dedicated electronic data capturing (EDC) system (REDCap DMS, https://www.project-redcap.org/), hosted by the server infrastructure of the Federal University of Goias. Data will be entered in REDCap using either the web-based application or the REDCap mobile app for iOS/Android. Baseline and longitudinal health-related data, and patient identifying codes used for the analysis will be entered in a REDCap database. The Report Builder will be used to create customized reports that are queried in real time.
Supporting information: Study protocol
Time frame: Data will be available after publication of the results in high-impact journals, and until two years hereafter
Access criteria: Upon request to the study coordinator
Ran from Mar 2021 to primary completion in Nov 2022, 20 months.
Of 46 non-industry interventional studies with no phase under Mouth, Edentulous, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's 20 months is below that.
Counting every sponsor, half of 54 studies reached it within 24 months; a quarter within 12 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidade Federal de Goias